Une avancée historique : le #lénacapavir injectable sera disponible à 40 $US/an dans 120 pays à revenu faible et intermédiaire. Un outil révolutionnaire de prévention du #VIH, accessible en un temps record. 🔗 unitaid.org/lenacapavir-fr

💉 From $42,250 to $40 — a massive win for equitable HIV prevention. Thanks to catalytic funding & technical support from the @gatesfoundation.bsky.social, @unitaid.bsky.social, and others, the cost for the two annual shots of Lenacapavir will drop to $40. @unaids.org @iasociety.bsky.social 📖⬇️ & 🙏🔁

📢 Estos días se han anunciado acuerdos para producir genéricos de #lenacapavir, la inyección preventiva contra el VIH que se aplica cada 6 meses. 💉 A partir de 2027 podría costar 40 dólares al año. Un avance impulsado por @unitaid.bsky.social y socios, una muy buena noticia para ampliar el acceso.

We all need some good news 👏🏽👏🏽👏🏽 “The revolutionary HIV prevention tool, injectable lenacapavir, will be available at a cost of US$40 a year in 120 low- and middle-income countries starting in 2027” @unitaid.bsky.social CHAI Wits RHI unitaid.org/news-blog/le...

Unitaid, CHAI, Wits RHI & Dr. Reddy's Laboratories have secured a US$40 annual price for injectable lenacapavir, a twice-yearly HIV prevention shot. Instead of the usual decade, generics are expected by 2027, just two years after first approvals. Learn more: unitaid.org/lenacapavir

🌍 MPP joined the Joint @who.int @unaids.org @unitaid.bsky.social annual consultation! Judith Federhofer shared updates on long-acting HIV treatment and the CAB-LA licence amendment for treatment + PrEP. @eburrone.bsky.social discussed access and pricing for #long-acting prevention in LMICs.

"How #Mpox revealed an epidemic of untreated #HIV in #SierraLeone – as Trump’s aid cuts begin to bite"

🏙 Every year, we welcome participants from around the world to Berlin – the vibrant host city of the annual WHS.  👉 Join us this October at #WHS2025. Be part of the leading global platform for health and experience Berlin yourself  🔗 https://f.mtr.cool/cqzuvjqpuf

🤝Strengthening TB care for children in the Philippines! Interest-holders in the Philippines came together in a recent forum to finalize a policy that will make pediatric #tuberculosis (TB) testing more timely, accurate, and child-friendly.🧒 @unitaid.bsky.social #TBSky

Spatial mosquito repellents could transform malaria control. A new $18.1m Unitaid-funded project, led by CRID in Cameroon with support from @LSTMnews, will trial this innovative tool to help accelerate malaria elimination. 🔗 lstm.ac/CRIDSpatialR... #Malaria #GlobalHealth

👏 We welcome @stoptb.bsky.social’s historic price cut for bedaquiline, lowering DR-TB treatment costs to under $300. This vital boost to care comes as countries face record pressure on health budgets, showing how advocacy and partnerships make medicines affordable. 🔗 www.stoptb.org/news/breakin...

Malaria kills nearly 600,000 Africans each year, mostly children. @who.int-approved spatial emanators, developed through Unitaid-funded studies, aim to fill the protection gap left by bed nets. Learn more: trt.global/afrika-engli...

📢 CHAI and Unitaid are seeking Expressions of Interest from gas suppliers in West and Central Africa. This exploratory step aims to assess potential for future work to expand access to affordable medical oxygen in the region. Learn more: www.clintonhealthaccess.org/rfp/cei-fina...

Unitaid champions community-led responses because they build trust, reach and sustainability. Young people, people living with HIV and marginalized groups help design the policies and programs that save lives. Learn more: unitaid.org/news-blog/yo...

Rising temperatures can compromise the effectiveness of medicines and health tools. Join @unitaid.bsky.social and partners on 2 Sept (1–3 PM CEST) for a virtual event about the climate-related impacts on the heat stability of health products. Register here: www.atachcommunity.com/atach-commun...

With nearly US$50M in new funding, Unitaid is supporting African-led innovation to produce essential diagnostics and medicines. MADE and MedSuRe Africa will boost local expertise, expand production, and strengthen health security. Learn more: www.afro.who.int/news/health-...

On 2 September, Unitaid and partners will convene an ATACH Technical Meeting to explore how climate change affects the safety, quality and availability of essential medicines and diagnostics. Details and registration: www.atachcommunity.com/atach-commun...

“Even though the FRESH trial was not a home run, achieving long-term viral control in 20% of the participants is exciting... It has brought hope to the community that progress is being made.” @npr.org #IAS2025 #HIV

Introducing MADE in Africa: a new $11M initiative with @unitaid.bsky.social to boost regional #Diagnostics manufacturing. With a consortium of partners including @wacihealth.bsky.social, MADE will strengthen supply chains & support African manufacturers in making high-quality tests. #MadeInAfrica

👏🏽 Two new investments by @unitaid.bsky.social will strengthen regional diagnostics and medicines manufacturing in Africa. The programs, led by @path.org and USP, will lay the groundwork for continental resilience and growth.

Africa imports over 95% of its pharmaceutical ingredients. Our new investments, supported by the @ec.europa.eu, will help shift this reality by working with @path.org and U.S. Pharmacopeia (USP) to strengthen local production of diagnostics and medicines. Learn more: unitaid.org/news-blog/un...

A healthcare worker with a smartphone could screen for cervical cancer in real time. With AI-assisted AVE, this vision can become a reality for women in low-resource settings. CHAI and Unitaid seek partners to make it happen. Find out more: www.clintonhealthaccess.org/rfp/invitati...

En cette Journée mondiale contre les moustiques, découvrez comment le modèle camerounais du CPP aide à maintenir en bonne santé Bouhemé et d’autres jeunes enfants exposés au paludisme : www.youtube.com/watch?v=yB9u... @psiimpact.bsky.social

Over 80% of malaria cases in Africa are treated with one drug combination. If resistance spreads, millions could be left without effective treatment. STOP-AMDR introduces multiple first-line therapies to reduce this risk. Learn more: unitaid.org/news-blog/un...

The fight against malaria has a new weapon. Spatial repellents, backed by Unitaid-funded research, are now recommended by WHO, alongside bed nets. Our $18M investment will help take them further and faster. Learn more: unitaid.org/news-blog/un...

En colaboración con la OPS, nuestra respuesta integral al VIH avanzado en Brasil aborda no solo el diagnóstico y el tratamiento, sino también las barreras sociales como el estigma y la falta de acceso a la salud. Conozca más: www.youtube.com/watch?v=iOJD...

We're looking forward to this next month. CELT are presenting and some #LONGEVITYproject work, funded by @unitaid.bsky.social, is being represented as well. If you're there, please find us to say hi.

In Kisenyi, community sensitization under the THRIVE project is giving children with advanced HIV disease a fighting chance, says Medical Officer Peter Aknoyera. Learn more: youtube.com/watch?v=CK42hmcl6c8

CELT's #LONGEVITYproject research, funded by @unitaid.bsky.social, includes long-acting tuberculosis preventative therapies for patients in low- and middle- income countries, to help people avoid contracting TB disease. Find out more about LONGEVITY's TB work: www.liverpool.ac.uk/centre-of-ex...

CHAI’s latest HIV Market Impact Memo, supported by Unitaid, exposes the human toll of funding cuts: steep drops in HIV testing, treatment & PrEP. Together, we're working to protect access and strengthen systems before hard-won gains are lost. Learn more: www.clintonhealthaccess.org/report/hiv-m...

Con menos financiación y más presión sobre los sistemas de salud, hacen falta nuevas formas de garantizar el acceso a la innovación y reforzar los sistemas sanitarios liderados por los países. Lo plantea @unitaid.bsky.social en su último informe sobre salud global. unitaid.org/news-blog/we...

90% of infants infected with hepatitis B at birth develop a lifelong infection. This threat is largely preventable with the #HepB birth dose vaccine. PATH, @gavi.org & @unitaid.bsky.social aim to ensure this lifesaving protection reaches more babies: www.path.org/our-impact/m... #WorldHepatitisDay

#LONGEVITYproject partner @treatmentactiongroup.org illustrated a #WorldHepatitisDay storyboard It's Sibusiso Dlamini's HCV experience, which is the story of how important accessible care is for HCV diagnosis, treatment and aftercare www.treatmentactiongroup.org/publication/... @unitaid.bsky.social

Unitaid was proud to join #IAS2025, where we presented our work on HIV alongside partners, launched SAFEStart+, engaged with communities, visited health sites in Kigali, and reaffirmed support to Rwanda to eliminate cervical cancer, support the HIV response, and tackle other diseases.

At clinics like Maria Rantho in South Africa, young women like Thato Mtshweni are leading the charge. They want choices that work for them, and lenacapavir could be the most empowering option yet. We’re working to make that choice possible. Learn more: unitaid.org/news-blog/le...

Mettre fin au VIH demande plus que des innovations : il faut de la volonté politique, du financement et l’engagement pour l’équité. Si nous tardons à agir, les infections repartiront à la hausse. C’est maintenant qu’il faut agir. unitaid.org/fr/news-blog...

Long-acting therapeutics are busy: @medicinespatentpool.org & ViiV Healthcare extend voluntary licencing agreement to enable access to LA HIV injectable treatment @unitaid.bsky.social launched funding to support rollout of lenacapavir in sub-Saharan Africa More: www.liverpool.ac.uk/centre-of-ex...

“You challenge us, and you lead,” said WHO’s Nathan Ford to civil society. At the Unitaid–AfroCAB session, one message was clear: communities are not recipients of care, they drive change. When those most affected shape the response, policy becomes progress. #IAS2025

At the Unitaid booth with AfroCAB, Jean Claude Cyiza shared how Rwanda tackles advanced HIV disease through monthly peer-led education, partnerships with health facilities, and digital platforms. Community-led awareness is driving real impact. #IAS2025

At our community session with AfroCAB at the Unitaid booth, Nathan Ford (WHO) emphasized that communities don't just inform WHO guidelines, they challenge, shape, and often lead them. Civil society drives the agenda. #IAS2025

At our community session with AfroCAB at the Unitaid booth, Dr. Duneton shared how community insights turned skepticism into impact. From HIV to cervical cancer, communities shaped testing tools and drive innovation. Unitaid listens and adapts. #IAS2025

Dr. Grinsztejn introduced ImPrEP LEN Brasil, the first lenacapavir implementation study in Latin America. Participants will choose between oral PrEP and lenacapavir, with the study tracking persistence, switching and user behavior, supported by adapted mHealth tools across the PrEP journey. #IAS2025

Carmen Pérez Casas at #IAS2025 identified two key drivers for long-acting PrEP success: low-cost, quality-assured products and delivery approaches that maximize epidemic impact. Unitaid is working on both fronts with urgency.

At #IAS2025, Maria Cristina Pimenta de Oliveira shared that mHealth-enhanced counselling gave providers more time to address concerns, helping build trust in PrEP options. Addressing contextual barriers and knowledge gaps is key to reaching those most vulnerable to HIV.

At #IAS2025, Thiago Silva Torres reinforced the need for equity in PrEP programs. The ImPrEP CAB Brasil cohort was largely composed of Black or mixed-race participants, i.e. those often left behind by traditional prevention models.

At #IAS2025, Dr. Artur Kalichman of Brazil’s Ministry of Health emphasized the critical role of implementation science in shaping effective HIV prevention policy. Studies like ImPrEP, funded by Unitaid, are essential tools for delivering real-world solutions.

@drduneton.bsky.social opened our #IAS2025 symposium by highlighting Brazil’s pivotal role in HIV prevention, recognizing its public health program as a global model. Unitaid is proud to support the science that turns policy into access.

As #IAS2025 begins, Dr. Valdiléa Gonçalves Veloso Dos Santos of Fiocruz welcomed attendees to our satellite symposium on implementing long-acting PrEP. We are honored to co-host this vital discussion with leading voices from Brazil and beyond.

Each year, 15 million people in Africa need oxygen. Unitaid’s partnership with Nikkiso brings modular oxygen plants to Kenya and Tanzania, helping close a deadly supply gap and reducing reliance on external sources. Learn more: www.gasworld.com/story/nikkis...

Carmen Pérez Casas discusses how Unitaid’s investments in AHD, including the THRIVE project, are supporting country-led strategies to scale access to the AHD package of care for adults and children, whilst navigating the emerging funding challenges. #IAS2025 www.youtube.com/watch?v=Pdqj...